{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:38:29Z","timestamp":1790789909818,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10147-022-02171-3","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T05:02:30Z","timestamp":1652418150000},"page":"1264-1272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma"],"prefix":"10.1007","volume":"27","author":[{"given":"Sho","family":"Osawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-751X","authenticated-orcid":false,"given":"Masahiko","family":"Tosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Tokue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"2171_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","volume":"115","author":"N Sanai","year":"2011","unstructured":"Sanai N, Polley MY, McDermott MW et al (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3\u20138","journal-title":"J Neurosurg"},{"key":"2171_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/bjh.15661","volume":"184","author":"CP Fox","year":"2019","unstructured":"Fox CP, Fox CP, Phillips EH et al (2019) Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. Br J Haematol 184:348\u2013363","journal-title":"Br J Haematol"},{"key":"2171_CR3","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/RCT.0000000000000636","volume":"41","author":"JB Wen","year":"2017","unstructured":"Wen JB, Huang WY, Xu WX et al (2017) Differentiating primary central nervous system lymphomas from glioblastomas and inflammatory demyelinating pseudotumor using relative minimum apparent diffusion coefficients. J Comput Assist Tomogr 41:904\u2013909","journal-title":"J Comput Assist Tomogr"},{"key":"2171_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3174\/ajnr.A5023","volume":"38","author":"X Lin","year":"2017","unstructured":"Lin X, Lee M, Buck O et al (2017) Diagnostic accuracy of T1-weighted dynamic contrast-enhanced-MRI and DWI-ADC for differentiation of glioblastoma and primary CNS lymphoma. AJNR Am J Neuroradiol 38:485\u2013491","journal-title":"AJNR Am J Neuroradiol"},{"key":"2171_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112948","volume":"9","author":"SJ Ahn","year":"2014","unstructured":"Ahn SJ, Shin HJ, Chang JH et al (2014) Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI methods. PLoS One 9:e112948","journal-title":"PLoS One"},{"key":"2171_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00234-012-1089-6","volume":"55","author":"K Yamashita","year":"2013","unstructured":"Yamashita K, Yoshiura T, Hiwatashi A et al (2013) Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and 18F-fluorodeoxyglucose positron emission tomography. Neuroradiology 55:135\u2013143","journal-title":"Neuroradiology"},{"key":"2171_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12149-011-0483-1","volume":"25","author":"K Makino","year":"2011","unstructured":"Makino K, Hirai T, Nakamura H et al (2011) Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. Ann Nucl Med 25:432\u2013438","journal-title":"Ann Nucl Med"},{"key":"2171_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s12149-014-0851-8","volume":"28","author":"S Yamaguchi","year":"2014","unstructured":"Yamaguchi S, Hirata K, Kobayashi H et al (2014) The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma. Ann Nucl Med 28:603\u2013609","journal-title":"Ann Nucl Med"},{"key":"2171_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s002590050487","volume":"26","author":"R Hustinx","year":"1999","unstructured":"Hustinx R, Smith RJ, Benard F et al (1999) Can the standardized uptake value characterize primary brain tumors on FDG-PET? Eur J Nucl Med 26:1501\u20131509","journal-title":"Eur J Nucl Med"},{"key":"2171_CR10","first-page":"1162","volume":"35","author":"S Dethy","year":"1994","unstructured":"Dethy S, Goldman S, Blecic S et al (1994) Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 35:1162\u20131166","journal-title":"J Nucl Med"},{"key":"2171_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF02988258","volume":"17","author":"N Tsuyuguchi","year":"2003","unstructured":"Tsuyuguchi N, Sunada I, Ohata K et al (2003) Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med 17:47\u201351","journal-title":"Ann Nucl Med"},{"key":"2171_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/135245859700300102","volume":"3","author":"C Schiepers","year":"1997","unstructured":"Schiepers C, Van Hecke P, Vandenberghe R et al (1997) Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler 3:8\u201317","journal-title":"Mult Scler"},{"key":"2171_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/247152","volume":"2013","author":"N Kawai","year":"2013","unstructured":"Kawai N, Miyake K, Yamamoto Y et al (2013) 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma. Biomed Res Int 2013:247152","journal-title":"Biomed Res Int"},{"key":"2171_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1102\/1470-7330.2013.0039","volume":"13","author":"H Gao","year":"2013","unstructured":"Gao H, Jiang X (2013) Progress on the diagnosis and evaluation of brain tumors. Cancer Imaging 13:466\u2013481","journal-title":"Cancer Imaging"},{"key":"2171_CR15","first-page":"1777","volume":"41","author":"Y Akiyama","year":"2000","unstructured":"Akiyama Y, Moritake K, Yamasaki T et al (2000) The diagnostic value of 123I-IMP SPECT in non-Hodgkin\u2019s lymphoma of the central nervous system. J Nucl Med 41:1777\u20131783","journal-title":"J Nucl Med"},{"key":"2171_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s002590000408","volume":"28","author":"T Yoshikai","year":"2001","unstructured":"Yoshikai T, Fukahori T, Ishimaru J et al (2001) 123I-IMP SPET in the diagnosis of primary central nervous system lymphoma. Eur J Nucl Med 28:25\u201332","journal-title":"Eur J Nucl Med"},{"key":"2171_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/A:1022583610812","volume":"61","author":"J Shinoda","year":"2003","unstructured":"Shinoda J, Yano H, Murase S et al (2003) High 123I-IMP retention on SPECT image in primary central nervous system lymphoma. J Neurooncol 61:261\u2013265","journal-title":"J Neurooncol"},{"key":"2171_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12149-013-0711-y","volume":"27","author":"T Kuwako","year":"2013","unstructured":"Kuwako T, Mizumura S, Murakami R et al (2013) Voxel-based analysis of (201)Tl SPECT for grading and diagnostic accuracy of gliomas: comparison with ROI analysis. Ann Nucl Med 27:493\u2013501","journal-title":"Ann Nucl Med"},{"key":"2171_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/BF02988641","volume":"16","author":"H Otsuka","year":"2002","unstructured":"Otsuka H, Shinbata H, Hieda M et al (2002) The retention indices of 201Tl-SPECT in brain tumors. Ann Nucl Med 16:455\u2013459","journal-title":"Ann Nucl Med"},{"key":"2171_CR20","first-page":"5","volume":"41","author":"D Sun","year":"2000","unstructured":"Sun D, Liu Q, Liu W et al (2000) Clinical application of 201Tl SPECT imaging of brain tumors. J Nucl Med 41:5\u201310","journal-title":"J Nucl Med"},{"key":"2171_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10014-009-0257-9","volume":"27","author":"K Asano","year":"2010","unstructured":"Asano K, Takeda T, Nakano T et al (2010) Correlation of MIB-1 staining index and (201)Tl-SPECT retention index in preoperative evaluation of malignancy of brain tumors. Brain Tumor Pathol 27:1\u20136","journal-title":"Brain Tumor Pathol"},{"key":"2171_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/00006231-199907000-00007","volume":"20","author":"S Taki","year":"1999","unstructured":"Taki S, Kakuda K, Kakuma K et al (1999) 201Tl SPET in the differential diagnosis of brain tumours. Nucl Med Commun 20:637\u2013645","journal-title":"Nucl Med Commun"},{"key":"2171_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1054\/jocn.2002.1142","volume":"9","author":"H Katano","year":"2002","unstructured":"Katano H, Karasawa K, Sugiyama N et al (2002) Comparison of thallium-201 uptake and retention indices for evaluation of brain lesions with SPECT. J Clin Neurosci 9:653\u2013658","journal-title":"J Clin Neurosci"},{"key":"2171_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijrobp.2012.03.008","volume":"85","author":"S Matsunaga","year":"2013","unstructured":"Matsunaga S, Shuto T, Takase H et al (2013) Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors. Int J Radiat Oncol Biol Phys 85:47\u201352","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2171_CR25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.jocn.2007.12.008","volume":"15","author":"J Tie","year":"2008","unstructured":"Tie J, Gunawardana DH, Rosenthal MA (2008) Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT. J Clin Neurosci 15:1327\u20131334","journal-title":"J Clin Neurosci"},{"issue":"Suppl","key":"2171_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3171\/sup.2005.102.s_supplement.0266","volume":"102","author":"T Serizawa","year":"2005","unstructured":"Serizawa T, Saeki N, Higuchi Y et al (2005) Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. J Neurosurg 102(Suppl):266\u2013271","journal-title":"J Neurosurg"},{"key":"2171_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40644-016-0098-9","volume":"16","author":"H Malikova","year":"2016","unstructured":"Malikova H, Koubska E, Weichet J et al (2016) Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma? Cancer Imaging 16:40","journal-title":"Cancer Imaging"},{"key":"2171_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"2171_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.crad.2011.03.006","volume":"66","author":"YZ Tang","year":"2011","unstructured":"Tang YZ, Booth TC, Bhogal P et al (2011) Imaging of primary central nervous system lymphoma. Clin Radiol 66:768\u2013777","journal-title":"Clin Radiol"},{"key":"2171_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","volume":"92","author":"B Bataille","year":"2000","unstructured":"Bataille B, Delwail V, Menet E et al (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92:261\u2013266","journal-title":"J Neurosurg"},{"key":"2171_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ejrad.2010.01.017","volume":"79","author":"E Senocak","year":"2011","unstructured":"Senocak E, Oguz KK, Ozgen B et al (2011) Parenchymal lymphoma of the brain on initial MR imaging: a comparative study between primary and secondary brain lymphoma. Eur J Radiol 79:288\u2013294","journal-title":"Eur J Radiol"},{"key":"2171_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00234-020-02377-0","volume":"62","author":"X Lin","year":"2020","unstructured":"Lin X, Khan IRA, Seet YHC et al (2020) Atypical radiological findings of primary central nervous system lymphoma. Neuroradiology 62:669\u2013676","journal-title":"Neuroradiology"},{"key":"2171_CR33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/00004647-199609000-00003","volume":"16","author":"H Iida","year":"1996","unstructured":"Iida H, Akutsu T, Endo K et al (1996) A multicenter validation of regional cerebral blood flow quantitation using [123I] iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab 16:781\u2013793","journal-title":"J Cereb Blood Flow Metab"},{"key":"2171_CR34","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.2967\/jnumed.110.078352","volume":"51","author":"H Iida","year":"2010","unstructured":"Iida H, Nakagawara J, Hayashida K et al (2010) Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine. J Nucl Med 51:1624\u20131631","journal-title":"J Nucl Med"},{"key":"2171_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/00003072-198810000-00013","volume":"13","author":"S Nakano","year":"1988","unstructured":"Nakano S, Kinoshita K, Jinnouchi S et al (1988) Unusual uptake and retention of I-123 IMP in brain tumors. Clin Nucl Med 13:742\u2013747","journal-title":"Clin Nucl Med"},{"key":"2171_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF00328188","volume":"30","author":"T Nishimura","year":"1988","unstructured":"Nishimura T, Hayashida K, Uehara T et al (1988) Two patients with meningioma visualized as high uptake by SPECT with N-isopropyl-p-iodo-amphetamine (I-123). Neuroradiology 30:351\u2013354","journal-title":"Neuroradiology"},{"key":"2171_CR37","first-page":"240","volume":"31","author":"S Nishizawa","year":"1990","unstructured":"Nishizawa S, Higa T, Kuroda Y et al (1990) Increased accumulation of N-isopropyl-(I-123)p-iodoamphetamine in bronchial carcinoid tumor. J Nucl Med 31:240\u2013242","journal-title":"J Nucl Med"},{"key":"2171_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3171\/jns.1989.71.3.0342","volume":"71","author":"KL Black","year":"1989","unstructured":"Black KL, Hawkins RA, Kim KT et al (1989) Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71:342\u2013346","journal-title":"J Neurosurg"},{"key":"2171_CR39","first-page":"2085","volume":"34","author":"N Oriuchi","year":"1993","unstructured":"Oriuchi N, Tamura M, Shibazaki T et al (1993) Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 34:2085\u20132089","journal-title":"J Nucl Med"},{"key":"2171_CR40","first-page":"1029","volume":"32","author":"H Nagai","year":"2004","unstructured":"Nagai H, Yamasaki T, Yamamoto Y et al (2004) Evaluation of brain tumors by simultaneous dual isotope SPECT with 201Tl-chloride and 99mTc-MIBI [in Japanese]. No Shinkei Geka 32:1029\u20131037","journal-title":"No Shinkei Geka"},{"key":"2171_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3171\/jns.1998.89.1.0060","volume":"89","author":"RB Schwartz","year":"1998","unstructured":"Schwartz RB, Holman BL, Polak JF et al (1998) Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 89:60\u201368","journal-title":"J Neurosurg"},{"key":"2171_CR42","first-page":"1187","volume":"12","author":"RB Schwartz","year":"1991","unstructured":"Schwartz RB, Carvalho PA, Alexander E 3rd et al (1991) Radiation necrosis vs high-grade recurrent glioma: differentiation by using dual-isotope SPECT with 201TI and 99mTc-HMPAO. AJNR Am J Neuroradiol 12:1187\u20131192","journal-title":"AJNR Am J Neuroradiol"},{"key":"2171_CR43","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/leu.2011.169","volume":"25","author":"M Deckert","year":"2011","unstructured":"Deckert M, Engert A, Bruck W et al (2011) Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia 25:1797\u20131807","journal-title":"Leukemia"},{"key":"2171_CR44","first-page":"532","volume":"33","author":"SS Rosenfeld","year":"1992","unstructured":"Rosenfeld SS, Hoffman JM, Coleman RE et al (1992) Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 33:532\u2013536","journal-title":"J Nucl Med"},{"issue":"20","key":"2171_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020140","volume":"99","author":"HO Kim","year":"2020","unstructured":"Kim HO, Kim JS, Kim SO et al (2020) Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography. Medicine (Baltimore) 99(20):e20140","journal-title":"Medicine (Baltimore)"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02171-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02171-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02171-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T04:28:16Z","timestamp":1658723296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02171-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2171"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02171-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"6 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors declare no conflicts of interest pertaining to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted under the institutional review board approval (Gunma University Hospital Clinical Research Review Board, Clinical Investigation and Research Unit, Gunma University Hospital, No. HS2020-083).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}